Cargando…

Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System

BACKGROUND: Stage IV breast cancer, also known as metastatic breast cancer (mBC), is not a curable condition. However, treatment can prolong life, delay the progression of the cancer, or improve quality of life. Currently, patients with mBC are often treated with chemotherapy. Patients often experie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashid, Nazia, Koh, Han A., Baca, Hilda C., Li, Zhaoliang, Malecha, Susan, Abidoye, Oyewale, Masaquel, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398121/ https://www.ncbi.nlm.nih.gov/pubmed/26402387 http://dx.doi.org/10.18553/jmcp.2015.21.10.863

Ejemplares similares

Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system
por: Rashid, Nazia, et al.
Publicado: (2016)

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
por: Hansen, Ryan N, et al.
Publicado: (2014)

EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
por: Sattler, Martin, et al.
Publicado: (2008)

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2013)

Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
por: Ge, Pu, et al.
Publicado: (2023)

Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
por: Guérin, Annie, et al.
Publicado: (2014)

The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients
por: Tachi, Tomoya, et al.
Publicado: (2015)

Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative Chemotherapy
por: Hong, Yong Joo, et al.
Publicado: (2014)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy‐induced adverse events
por: Lv, Dan, et al.
Publicado: (2022)

Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
por: Fradley, Michael G., et al.
Publicado: (2023)

A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast Cancer
por: Wheelden, Megan, et al.
Publicado: (2018)

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
por: Gallagher, Christopher M., et al.
Publicado: (2016)

Patients’ experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy
por: Bæksted, Christina Witt, et al.
Publicado: (2019)

Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients
por: Sanguanboonyaphong, Phitjira, et al.
Publicado: (2022)

Modeling and Analysis of Breast Cancer with Adverse Reactions of Chemotherapy Treatment through Fractional Derivative
por: Tang, Tao-Qian, et al.
Publicado: (2022)

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis
por: Xun, Xueqiong, et al.
Publicado: (2023)

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
por: Hagiwara, Yasuhiro, et al.
Publicado: (2017)

Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
por: Guha, Avirup, et al.
Publicado: (2022)

Microfluidic Modules Integrated with Microwave Components—Overview of Applications from the Perspective of Different Manufacturing Technologies
por: Jasińska, Laura, et al.
Publicado: (2021)

Chemotherapy Treatment Considerations in Metastatic Breast Cancer
por: Hanna, Kirollos, et al.
Publicado: (2021)

Adverse event detection by integrating twitter data and VAERS
por: Wang, Junxiang, et al.
Publicado: (2018)

Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer
por: Tanaka, Kazuhide, et al.
Publicado: (2018)

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
por: Shields, Lisa B E, et al.
Publicado: (2021)

Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
por: Leucht, Katharina, et al.
Publicado: (2022)

Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events
por: Saqlain, Farees, et al.
Publicado: (2020)

Atezolizumab induced immune-related adverse event mimicking conjunctival metastatic disease
por: Aschauer, Julia, et al.
Publicado: (2022)

Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
por: Gautron Moura, Bianca, et al.
Publicado: (2022)

Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection
por: Koo, Chieh Yang, et al.
Publicado: (2021)

Adolescents’ understanding of chemotherapy-related adverse events: a concept elicitation study
por: Silva-Rodrigues, Fernanda Machado, et al.
Publicado: (2022)

The Impact of Omitting 5-FU Bolus From mFOLFOX6 Chemotherapy Regimen on Hematological Adverse Events Among Patients With Metastatic Colorectal Cancer
por: Areepium, Nutthada, et al.
Publicado: (2023)

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer
por: Tripathy, Debu, et al.
Publicado: (2014)

Action after Adverse Events in Healthcare: An Integrative Literature Review
por: Liukka, Mari, et al.
Publicado: (2020)

Nasogastric/nasoenteric tube-related adverse events: an integrative review
por: Motta, Ana Paula Gobbo, et al.
Publicado: (2021)

The fourth education revolution
por: Seldon, Anthony, et al.
Publicado: (2018)

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
por: Wölffer, Marcus, et al.
Publicado: (2022)

Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
por: Meng, Lingbin, et al.
Publicado: (2023)

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
por: Gallagher, Christopher M., et al.
Publicado: (2016)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uul28845fmhtjqj02uc24lq6ff